SCHEMBL21032248

SCHEMBL21032248

c1ccc(-c2cccc(-c3nc(-c4ccccc4)cc(-c4ccc(-c5ccc6c(c5)c5cc7nc(-c8ccccc8)c8ccccc8c7cc5n6-c5ccccc5)cc4)n3)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 3/20 0.34
LMNA P02545 2/20 0.34
WHR1 P49842 1/20 0.33
NTSR1 P30989 1/20 0.33
PTGER4 P35408 1/20 0.33
ATM Q13315 2/20 0.33
GLA P06280 1/20 0.33
DHODH Q02127 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
DHFR P00374 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031138 0.99 MEN1 (0.36) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL21031134 0.97 MEN1 (0.37) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL21031130 0.96 MEN1 (0.38) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL21031144 0.96 MEN1 (0.37) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL21030853 0.96 MEN1 (0.37) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL21031549 0.94 MEN1 (0.34) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL21031638 0.94 ATM (0.39) MEN1KMT2AKDM4EMAPTWHR1
SCHEMBL21031636 0.94 ATM (0.39) MEN1KMT2AKDM4EMAPTWHR1
SCHEMBL21031554 0.94 ATM (0.39) MEN1KMT2AKDM4EMAPTWHR1
SCHEMBL21031133 0.93 MEN1 (0.36) MEN1KMT2AKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190161485-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE SOULBRAIN CO., LTD. (KR) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190161485-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE DRD1, NR2E3, CRY1 MEN1 3006/4885KMT2A 2841/4885KDM4E 3904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.